ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,363 | -99.4% | 19,096 | -97.4% | 0.00% | -100.0% |
| Q3 2022 | $4,843,000 | +5.1% | 722,943 | -0.2% | 0.09% | -27.6% |
| Q2 2022 | $4,608,000 | +223.8% | 724,454 | +136.2% | 0.13% | +234.2% |
| Q1 2022 | $1,423,000 | +77.0% | 306,681 | +90.8% | 0.04% | +52.0% |
| Q4 2021 | $804,000 | -74.6% | 160,749 | +202.7% | 0.02% | -87.8% |
| Q4 2019 | $3,166,000 | -10.6% | 53,100 | -45.0% | 0.20% | -2.8% |
| Q3 2019 | $3,541,000 | +1357.2% | 96,600 | +1747.4% | 0.21% | +681.5% |
| Q2 2019 | $243,000 | -78.5% | 5,229 | -81.5% | 0.03% | -85.5% |
| Q1 2019 | $1,132,000 | – | 28,200 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |